Riggs Asset Management’s NeoGenomics NEO Stock Holding History

Riggs Asset Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-200	Closed	-$10K	–	319
2021 Q1	$10K	Hold	200	–	–	﹤0.01%	213
2020 Q4	$11K	Buy	+200	New	+$9.04K	﹤0.01%	198

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Riggs Asset Management's NEO Position: Q2 2021 in Review

Riggs Asset Management sold out of NeoGenomics (NEO) in Q2 2021, closing a stake of 200 shares — an estimated $10K sold.

Riggs Asset Management first reported a position in NEO in Q4 2020 and held it in 2 quarters. The position peaked at $11K in Q4 2020. 311 funds tracked by Wall St. Rank hold NEO as of Q2 2021.

Riggs Asset Management reported no remaining NeoGenomics position as of Q2 2021 after selling out during the quarter.
Riggs Asset Management sold 200 NeoGenomics shares in Q2 2021, an estimated $10K.
Riggs Asset Management first reported a position in NeoGenomics in Q4 2020 and held it in 2 quarters.
Riggs Asset Management's NeoGenomics position peaked at $11K in Q4 2020.
311 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2021.

Based on Riggs Asset Management's 13F filing for Q2 2021, filed 16 Jul 2021.